Table 3

The number of patients received the care, the number of people in the target groups and the proportion of patients received the care in 2016 for the whole country by gender of GPs with 95% CIs

	Number of patients received the care		Number of people in target group		Proportion of patients received the care
	Male GPs	Female GPs	Male GPs	Female GPs	Male GPs	Female GPs	P value
Influenza immunisation	172 150	159 893	865 187	796 380	19.9%(19.8–19.9)	20.1%(19.9–20.2)	0.004
Mammography screening	304 907	299 137	681 141	640 293	44.7%(44.6–44.9)	46.7%(46.5–46.9)	<0.001
Serum creatinine measurement	814 819	785 950	1 225 158	1 108 168	66.5%(66.4–66.6)	70.9%(70.8–71.0)	<0.001
Lipid measurement	752 737	735 502	1 261 490	1 139 843	59.7%(59.6–59.8)	64.5%(64.4–64.6)	<0.001
Beta-blocker application	48 202	42 184	90 112	80 723	53.5%(53.2–53.8)	52.3%(51.9–52.6)	<0.001
HbA1c measurement	192 370	179 474	250 575	222 690	76.8%(76.6–76.9)	80.6%(80.4–80.8)	<0.001
Eye examination	95 617	91 995	250 575	222 690	38.2%(37.9–38.4)	41.3%(41.1–41.5)	<0.001
Management of COPD	75 154	69 835	97 213	88 345	77.3%(77.1–77.6)	79.1%(78.8–79.3)	<0.001
Composite indicator	2 455 956	2 363 970	4 721 451	4 299 132	52.0%(51.9–52.1)	54.9%(54.9–55.0)	<0.001

COPD, chronic obstructive pulmonary disease; GPs, general practitioners; HbA1c, haemoglobin A1c.